RxDoctor Payments Data

Ony Achufusi, MD

Hospitalist · Munster, INNPI 1508857269

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 75.4% of it on its own, with 6 other manufacturers making up the rest. Among hospitalist clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$962in general payments, 2019–2025

Across 43 payments — averaging $22.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$725
  • Medtronic$81
  • Gilead$62
  • Novartis$39
  • Ceribell, Inc.$23
  • EKOS Corporation$17
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$962 in reported general payments places this provider in the 90th percentile of 423 hospitalist providers in Indiana.

See all hospitalist providers in Indiana

Medicare billing

Part B allowed, 2024
$87,777
Medicare patients
325
Services billed
990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$858
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic12$766
Insulin Lispro11$311
Pantoprazole Sodium39$238
CefuroximeCefuroxime Axetil14$147
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$120
Potassium Chloride14$112
Doxycycline Monohydrate16$84
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$73
Enalapril Maleate13$64
Furosemide22$47
Metoprolol Succinate12$43
Prednisone27$38

Paid to pharmacies, not to this prescriber.

Other hospitalist in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →